California became the home to the Aedes aegypti mosquito about a decade ago. Since then, it can be found from the Mexican border all the way to the northern California border with Oregon. It’s been found in 200 cities spread across 22 California counties. Its arrival was not welcome, however.
Category: Drug Prices & Regulations
Medicare Drug Plan Spending Growth to Double
A report published in Health Affairs estimates that Medicare Part D spending will rapidly increase in the coming years. The reasons are both good news and bad news. Basically, new drugs in the pipeline and an increasing array of specialty drugs will drive spending growth. From 2009 to 2018 spending on Medicare Part D drugs increased about…
What if Future Voters Could Vote?
An interview with Alex Tabarrok:
Future residents don’t have the vote, so we prevent building which placates the fears of current homeowners but prevents future residents from moving in. Future patients don’t have the vote, so we regulate drug prices at the expense of future new drug innovations and so forth. This has always been true, of course, but culture can be a solution to otherwise tough-to-solve incentive problems. America’s forward looking, pro-innovation, pro-science culture meant that in the past we were more likely to protect the future.
Drug Maker’s Copay Assistance Ended Up in Drug Plans’ Pockets
A while back I wrote about drug company copay assistance programs. The purpose of these is to entice patients to use higher-cost brand drugs by blunting health plan incentives for enrollees to choose lower-cost drug options.